secwatch / observer
8-K filed November 8, 2022, 6:59 PM ET ticker HUM CIK 0000049071
debt confidence high sentiment neutral materiality 0.50

Humana prices $1.25B senior notes offering, refinancing maturing debt

HUMANA INC

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

HUMANA INC entered into Underwriting Agreement with BofA Securities, Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and PNC Capital Markets LLC, as representatives of the several underwriters valued at $500 million aggregate principal amount of its 5.750% Senior Notes due 2028 and $750 million aggrega (effective 2022-11-07).

Action
entry
Agreement
underwriting
Counterparty
BofA Securities, Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and PNC Capital Markets LLC, as representatives of the several underwriters
Value
$500 million aggregate principal amount of its 5.750% Senior Notes due 2028 and $750 million aggrega
Effective
2022-11-07
Exact text from the filing
On November 7, 2022, Humana Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with BofA Securities, Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and PNC Capital Markets LLC, as representatives of the several underwriters (together, the “Underwriters”), pursuant to which the Company agreed to issue and sell to the Underwriters $500 million aggregate principal amount of its 5.750% Senior Notes due 2028 (the “2028 Senior Notes”) and $750 million aggregate principal amount of its 5.875% Senior Notes due 2033 (the “2033 Senior Notes” and, together with the 2028 Senior Notes, the “Senior Notes”), in accordance with the terms and conditions set forth in the Underwriting Agreement.
View on SEC.gov

Browse all material agreements →

HUMANA INC filing history →

Source: SEC EDGAR
accession 0001193125-22-280280
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.